Author: Chang W-K. Yang K.D. Chuang H. Jan J-T. Shaio M-F.
Publisher: Academic Press
ISSN: 1521-6616
Source: Clinical Immunology, Vol.104, Iss.2, 2002-08, pp. : 151-160
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Glutamine is the most abundant amino acid in the body. A decrease of plasma glutamine concentrations is found in catabolic stress and is related to susceptibility to infections. Glutamine is known to modulate lymphocyte activation; however, little is known about glutamine modulation of cell death of activated human T cells. Using Jurkat T cells, we investigated glutamine modulation of T-cell apoptosis activated by PMA plus ionomycin. We found that glutamine at various concentrations significantly enhanced IL-2 production, cell proliferation, and cell viability of Jurkat T cells. Glutamine also decreased the number of apoptotic cells stimulated with PMA plus ionomycin as demonstrated by flow cytometry. Meanwhile, glutamine down-regulated CD95 and CD95L expression, but up-regulated CD45RO and Bcl-2 expression in activated T cells. Further investigation of CD95-mediated caspase activities revealed that supplementation of glutamine significantly decreased caspase-3 and caspase-8 activities in activated T cells. Since oxidative stress is closely associated with induction of lymphocyte apoptosis, we found that glutamine significantly increased glutathione (GSH), but decreased reactive oxygen species levels in activated T cells. Blockade of intracellular GSH formation enhanced, but exogenous GSH supplementation decreased, activated T-cell apoptosis. Studying normal peripheral lymphoproliferation, we also found that the presence of glutamine increased lymphoproliferation as well as Bcl-2 and CD95 expression; but decreased CD95L and activation-induced T-cell death. Taken together, glutamine appeared to augment lymphoproliferation but suppressed activation-induced T-cell death in both Jurkat T cells and human peripheral T lymphocytes.
Related content
By Roozendaal R. Vellenga E. de Jong M.A. Traanberg K.F. Postma D.S. de Monchy J.G.R. Kauffman H.F.
International Immunology, Vol. 13, Iss. 4, 2001-04 ,pp. :
By Allison Janette Thomas Helen Beck Dianne Brady Jamie L. Lew Andrew M. Elefanty Andrew Kosaka Hiro Kay Thomas W. Huang David C. S.
International Immunology, Vol. 12, Iss. 1, 2000-01 ,pp. :
By Fujiwara I. Nakajima H. Mizuta N. Sakaguchi K. Yoshimura N. Yamagishi H. Oka T.
Transplantation Proceedings, Vol. 32, Iss. 5, 2000-08 ,pp. :